Institutional investors hold a majority ownership of AUXL through the 99.64% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2012, these large investors purchased a net $3.0 million shares.
| Other institutional | 57.56% |
| Mutual fund holders | 42.08% |
| Individual stakeholders | 29.73% |